Read about neuroblastoma diagnosis stories and the latest in neuroblastoma research.
Written by Katie Krispin. William “Will” Krispin was born on December 14, 2013. Just four and a half short months later, he developed a low-grade fever. I decided to bring him to urgent care.
William “Will” Krispin, Neuroblastoma Read More »
Meet Gold Getter Captain, Wes Chang! This year for Childhood Cancer Awareness Month, we interviewed our Gold Getter Captains to learn about their cancer survivor stories. Learn more about how you can help them #MakeItGoldForKids here. Current Age: 3 Diagnosis:
Wes Chang, Neuroblastoma Read More »
The CureSearch for Children’s Cancer Survivorship Council was formed in February 2014 to build awareness and support for childhood cancer survivors. We’re grateful to have a team of men and women who are dedicated to developing survivorship education and resources
A Mother Finds Strength for Her Daughter’s Cancer Read More »
(medicalxpress.com) – Pediatric oncologists from The Children’s Hospital of Philadelphia (CHOP) have reported their latest results in devising new treatments for stubbornly deadly forms of the childhood cancer neuroblastoma. Building on their previous experiences in treating some refractory subtypes of
New Drug May Overcome Treatment Resistance in a High-risk Children’s Cancer Read More »
New CureSearch Young Investigator Dr. Anthony Graves is studying molecular targets in N-Myc amplified neuroblastoma, a sub-type of the disease known to have poor outcomes. Dr. Graves studies the biology of a particular gene known to be involved in this high-risk sub-type.
Dr. Anthony Graves, Young Investigator: Neuroblastoma Read More »
(Science Daily) – Delving into the world of the extremely small, researchers are exploring how biodegradable nanoparticles can precisely deliver anticancer drugs to attack neuroblastoma, an often-deadly children’s cancer. By bringing together experts in pediatric oncology with experts in nanotechnology,
Nanoparticles May Exploit Tumor Weaknesses to Selectively Attack Cancers Read More »
(FDA.gov) – The U.S. Food and Drug Administration today approved Unituxin (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a type of cancer that most often occurs in young children. Neuroblastoma is a rare cancer that
FDA Approves First Therapy for High-Risk Neuroblastoma Read More »
13 Months Old at Diagnosis Our beautiful son, Tyler William Cordle, is the bravest and most amazing person I have ever known or will ever know in my life. After noticing obvious pain in his hip and leg area, I
Tyler Cordle, Neuroblastoma Read More »
3 Weeks Old at Diagnosis A short summary of our son Ty’s journey in just his first year. He was born June 15th, 2011 and was diagnosed with neuroblastoma by 3 weeks old. We found this after following up on
Ty Lundberg, Neuroblastoma Read More »
11 Months Old at Diagnosis On January 1, 2013, Jennifer and Josh Haynes’ life changed when Jennifer found a lump on the neck of their son, Trenton. She called their doctor, who assured her it was probably just a swollen
Trenton Haynes, Neuroblastoma Read More »
